市場調查報告書

子宮頸發育不良成市場 - 各產品類型、終端用戶、地區:市場規模、佔有率、展望、機會分析 (2020-2027年)

Cervical Dysplasia Market, By Product Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968723
出版日期 內容資訊 英文 145 Pages
商品交期: 2-3個工作天內
價格
子宮頸發育不良成市場 - 各產品類型、終端用戶、地區:市場規模、佔有率、展望、機會分析 (2020-2027年) Cervical Dysplasia Market, By Product Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月18日內容資訊: 英文 145 Pages
簡介

子宮頸發育不良成診斷市場,由於疾病盛行率的增加及定期診察的政府的診察計劃造成檢測試驗的利用相關意識高漲,預計在預測期間將大幅度成長。

本報告提供全球子宮頸發育不良成市場相關調查,市場概要,影響市場的因素分析,各市場區隔、各地區的市場分析,並提供主要企業簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各產品類型
    • 市場明細:各終端用戶
    • 市場明細:各地區
    • Coherent Opportunity Map (COM)

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的焦點
  • 產品銷售
  • PEST分析
  • 技術的進步
  • 法規方案
  • 合併和收購

第4章 全球子宮頸發育不良成市場:各產品類型

  • 簡介
  • 診斷試驗
  • 診斷設備

第5章 全球子宮頸發育不良成市場:各終端用戶

  • 簡介
  • 醫院
  • 診斷中心
  • 民間婦產科
  • 研究&學術機構
  • 外科門診診療所 (ASC)

第6章 全球子宮頸發育不良成市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第7章 競爭情形

  • 企業簡介
    • F. Hoffmann La-Roche Ltd.
    • QIAGEN NV
    • Becton, Dickinson and Company
    • OncoHealth Corporation
    • Quest Diagnostics, Inc.
    • Hologic, Inc.
    • Abbott Laboratories
    • ASKA Pharmaceutical Co. Ltd.
    • Asieris Pharmaceuticals
    • BetterLife Pharma Inc.
    • KinoPharma, Inc.

第8章 Section

目錄

Title:
Cervical Dysplasia Market, By Product Type (Diagnostic Test, Diagnostic Devices), By End User (Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic institutes, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

  • Cervical dysplasia is a precancerous condition characterized by abnormal growth of endocervical canal cells. Cervical dysplasia is also called as cervical intraepithelial neoplasia. Cervical dysplasia can be of two types based on the type of cells it affect - squamous intraepithelial lesion and glandular cell lesions. The cervical dysplasia diagnostic market is expected to witness significant growth over the forecast period, owing to increasing prevalence of disease and increasing awareness regarding utilization of detection test through government screening programmes for regular screening.

Key features of the study:

  • This report provides in-depth analysis of the Global Cervical Dysplasia market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Cervical Dysplasia market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, F. Hoffmann La-Roche Ltd., QIAGEN N.V., Becton, Dickinson and Company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., Abbott Laboratories, ASKA Pharmaceutical Co., Ltd., Asieris Pharmaceuticals, BetterLife Pharma Inc., and KinoPharma, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Cervical Dysplasia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cervical Dysplasia market

Detailed Segmentation:

  • Global Cervical Dysplasia Market, By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
  • Global Cervical Dysplasia Market, By End User:
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
  • Global Cervical Dysplasia Market, By Region:
  • North America
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Product Type:
    • Diagnostic Test
    • Diagnostic Devices
    • By End User
    • Hospitals
    • Diagnostic Centers
    • Private Gynecologists' Offices
    • Research & Academic institutes
    • Ambulatory Surgical Centers
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • F. Hoffmann La-Roche Ltd. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • QIAGEN N.V.
  • Becton, Dickinson and Company
  • OncoHealth Corporation
  • Quest Diagnostics, Inc.
  • Hologic, Inc.
  • Abbott Laboratories
  • ASKA Pharmaceutical Co., Ltd.
  • Asieris Pharmaceuticals
  • BetterLife Pharma Inc.
  • KinoPharma, Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Cervical Dysplasia Market, By Product Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Diagnostic Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Diagnostic Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

5. Global Cervical Dysplasia Market, By End User, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Private Gynecologists' Offices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Research & Academic institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Cervical Dysplasia Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • F. Hoffmann La-Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • QIAGEN N.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • OncoHealth Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Quest Diagnostics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hologic, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ASKA Pharmaceutical Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Asieris Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BetterLife Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • KinoPharma, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact